Dr Bruce Alexander
Dr Bruce Alexander has devoted his life to the improvement of physical and psychological health. He began his career as a medical research scientist, where he and coworkers were able to identify a crucial gene in the developement of leukaemia.
Most cancers are linked to or caused by lifestyle issues, for example smoking, eating, drinking, poor sleep or lack of exercise. Many cancers can be prevented by behavioural changes but unfortunately this is easier said than done. Hypnosis is an excellent technique for behavioural change as well as a useful tool to help resolve emotional and stress related issues.
In 1999 Bruce completed training in clinical hypnosis and psychotherapy at The Australian Academy of Hypnotic Science. Since that time he has helped thousands of private clients resolve a variety of physical and psychological health issues. He has applied his diverse range of research and clinical skills to the corporate sector by providing programs in stress resilience and smoking cessation.
Bruce also tutors Medical Students at Monash University and has lectured at The Australian Academy of Hypnotic Science.
Dr Bruce Alexander chats with Hughesy, Kate and Dave on Nova Radio.
Bachelor of Science, University of Melbourne
Doctor of Philosophy (Medicine), University of Melbourne
Diploma of Psychotherapy, Australian Academy of Hypnotic Science
Diploma of Health (Hypnosis), Australian Academy of Hypnotic Science
Certificate in Workplace Training (Category 1)
Certificate IV in Assessment and Workplace Training
Full Member, Australian Society of Clinical Hypnotherapists
The Ludwig Institute of Cancer Research, Australia
The University of Melbourne, Australia
The Institute of Molecular Pathology, Vienna
The Walter and Eliza Hall Institute, Australia
Monash University, Australia
The Australian Academy of Hypnotic Science
Phenotypic effect correlating with loss of a novel tumor suppressor gene: towards cloning by complementation.
Cook WD, Alexander BJ. Leukemia.
Establishment of multipotential and antigen presenting cell lines derived from myeloid leukemias in GM-CSF transgenic mice.
Rasko JE, Metcalf D, Alexander B, Strasser A, Begley CG. Leukemia.
Gene deletion explains both in vivo and in vitro generated chromosome 2 aberrations associated with murine myeloid leukemia.
Alexander BJ, Rasko JE, Morahan G, Cook WD. Leukemia.
Tumor-associated karyotypic lesions coselected with in vitro macrophage differentiation.
Alexander B, Berger R, Day LM, Hogarth PM, Feneziani A, Cook WD. Genes Chromosomes Cancer.